Results 21 to 30 of about 213,106 (383)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials

ESC Heart Failure, 2021
Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are both associated with increased levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP). It is known that AF impairs the diagnostic accuracy of NT‐proBNP for HF. The aim of
S. Werhahn, C. Becker, M. Mende, H. Haarmann, Kathleen Nolte, U. Laufs, S. Zeynalova, M. Löffler, N. Dagres, D. Husser, M. Dörr, S. Gross, S. Felix, A. Petersmann, C. Herrmann-Lingen, L. Binder, M. Scherer, G. Hasenfuss, B. Pieske, F. Edelmann, R. Wachter   +20 more
semanticscholar   +1 more source

NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure

Clinical pharmacology and therapy, 2021
N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a well‐established biomarker in heart failure (HF) but controversially discussed as a potential surrogate marker in HF trials.
W. Schmitt, H. Rühs, R. Burghaus, Christian Diedrich, Sulav Duwal, T. Eissing, D. Garmann, M. Meyer, B. Ploeger, J. Lippert   +9 more
semanticscholar   +1 more source

Impact of socioeconomic and cardiovascular risk factors on the effect of genetic variants associated with NT-proBNP

Scientific Reports, 2022
N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is an established biomarker for diagnosis of heart failure. The study aims to explore whether known cardiovascular risk factors, including education and income as indicators of socioeconomic ...
Emanuel Matusch, Mirjam Frank, Kaffer Kara, Amir A. Mahabadi, Nico Dragano, Raimund Erbel, Karl-Heinz Jöckel, Börge Schmidt   +7 more
doaj   +1 more source

Prognostic value of NT-proBNP in patients with severe COVID-19

Respiratory Research, 2020
Background The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern.
Lei Gao, D. Jiang, X. Wen, Xiao-cheng Cheng, Min Sun, B. He, Lin-na You, P. Lei, Xiao-wei Tan, S. Qin, Guoqiang Cai, Dongyin Zhang   +11 more
semanticscholar   +1 more source

Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus

Cardiovascular Diabetology, 2021
Background Recently, the European Society of Cardiology (ESC) and European Association for the Society of Diabetes (EASD) introduced a new cardiovascular disease (CVD) risk stratification model to aid further treatment decisions in individuals with ...
Suriya Prausmüller, M. Resl, H. Arfsten, G. Spinka, R. Wurm, S. Neuhold, P. Bartko, G. Goliasch, Guido Strunk, N. Pavo, M. Clodi, M. Hülsmann   +11 more
semanticscholar   +1 more source

Characterization of NT-proBNP in Human Urine [PDF]

Clinical Chemistry, 2009
Abstract Background: Urine amino-terminal probrain natriuretic peptide (NT-proBNP) concentrations may exclude the presence of heart failure and provide insight into renal clearance mechanisms for human NT-proBNP. We characterized the molecular forms of urine NT-proBNP detected by immunoassay.
Zoltan H. Endre, Timothy G. Yandle, Suetonia C. Palmer, A. Mark Richards   +3 more
openaire   +2 more sources

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme

ESC Heart Failure, 2021
Aims Guidelines support the role of B‐type natriuretic peptide (BNP) and amino‐terminal pro‐BNP (NT‐proBNP) for risk stratification of patients in programmes to prevent heart failure (HF).
Claire Sweeney, Rebabonye B. Pharithi, Brian Kerr, Cristin Ryan, Fiona Ryan, Líbhan Collins, Carmel Halley, Matt Barrett, Chris J. Watson, Kenneth McDonald, Mark Ledwidge   +10 more
doaj   +1 more source

Diagnostic utility of total NT-proBNP testing by immunoassay based on antibodies targeting glycosylation-free regions of NT-proBNP

Clinical Chemistry and Laboratory Medicine, 2022
Objectives The N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) is a widely used heart failure (HF) biomarker. Commercial NT-proBNP immunoassays detect only a subfraction of endogenous NT-proBNP, as the antibodies target a region of NT ...
Lingpo Li, A. G. Semenov, E. E. Feygina, Chenchen Yang, Nan Wang, Chao Chen, Xinghai Hu, Xiaoqin Ni, Zhenlu Zhang   +8 more
semanticscholar   +1 more source

Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM)

Clinical Research in Cardiology, 2021
Peripartum cardiomyopathy (PPCM) is an important cause of pregnancy-associated heart failure worldwide. Although a significant number of women recover their left ventricular (LV) function within 12 months, some remain with persistently reduced systolic ...
J. Hoevelmann, E. Muller, F. Azibani, S. Kraus, J. Cirota, O. Briton, M. Ntsekhe, N. Ntusi, K. Sliwa, C. Viljoen   +9 more
semanticscholar   +1 more source

Pro-BNP Levels and Its Prognostic Role in Chronic Hypertensive Pregnancies: A Prospective Case-Control Study From A Tertiary Care Hospital

Hypertension in Pregnancy, 2021
Background: This study aimed to investigate the prognostic value of N-terminal B-type natriuretic peptide (NT-proBNP) in pregnancies with isolated chronic hypertension (HT).
Mehmet Akif Erdol, Atakan Tanacan, Hasan Eroglu, Nazan Vanli Tonyali, Mehmet Erdogan, Aykan Yucel, Nuray Yazihan, Dilek Sahin   +7 more
doaj   +1 more source